Additional Information Velaglucerase Alfa [VPRIV] is approved for funding under the Rare Disease Fund
INTRAVENOUS Select a brand starting with the letter: V VPRIV POWDER FOR SOLUTION FOR INFUSION 400 UNITS/VIAL [SIN16107P]